Biotest AG

Privately held: no public share price

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
0Diseases
Showing 1 of 1 assets
Target & Modality
Phase 3
Hepatitis B virus (HBV)Protein / enzyme therapeutic
Indication not yet linked

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.